Review Article
Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
Table 1
Key features of extracellular vesicles.
| EV types | Size | Biogenesis | Markers | Contents |
| Exosomes | 30–100 nm | Endolysosomal pathway. Released by exocytosis of multivesicular bodies | Tetraspanins (CD63, CD9, and CD81), Alix, and TSG101 | miRNAs and mRNA; lipids, DNA membrane proteins and lipids, cytokine receptors, and MHC molecules |
| Microvesicles/microparticles | 100–1000 nm | Cell surface. Outward budding of plasma membrane | Integrins, selectins, and CD40 ligand | mRNA, noncoding RNAs, membrane proteins, receptors, and cytoplasmic proteins |
| Apoptotic bodies | Up to 5000 nm | Cell surface. Released from cellular blebs during apoptosis | Phosphatidyl-serine | Nuclear fractions, cell organelles, DNA, rRNA, and mRNA |
|
|
EV: extracellular vesicles, MHC: major histocompatibility complex, mRNA: messenger RNA, miRNA: microRNA, rRNA: ribosomal RNA, and TSG101: tumor susceptibility gene 101.
|